Locations:
Search IconSearch

Research

Patient sneezing
May 12, 2025/Pulmonary/Research

Respiratory Virus Season: Strategies for Successful Navigation

Pearls to reduce the strain of RSV, COVID-19 and influenza infections

Pregnant woman with inhaler
March 27, 2025/Pulmonary/Research

Impact of GDM on Asthma During Pregnancy and Postpartum

Largest study examines factors affecting asthma exacerbations during and after pregnancy

Sarcoidosis granuloma
February 13, 2025/Pulmonary/Research

New Study Explores Efzofitimod as a Promising Alternative for Sarcoidosis Treatment

Initial findings demonstrate improved symptoms and reduced steroid dependence

Patient sleeping
August 7, 2024/Pulmonary/Research

Nocturnal Hypoxemia Linked to Muscle Wasting in COPD Patients

Findings show profound muscle loss variance between men and women

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Lung on computer screen

New Transplant Simulation Model Framework Addresses Limitations of Current Models

The agent-based model aims to improve prediction accuracy

Clostridioides difficile bacteria
May 28, 2024/Pulmonary/Research

New Study Points to Feasibility of Breath-Based Diagnostic Test for C. diff

VOC analysis could provide biological insight into risk factors associated with CDI

CPAP mask
April 2, 2024/Pulmonary/Research

Treatments for Obstructive Sleep Apnea: CPAP and Beyond

A review of conservative, pressure-based and surgical treatments for OSA

Image of lungs
February 28, 2024/Pulmonary/Research

New Cleveland Clinic-Led Research Highlights Novel Disease Monitoring Technique in Heart Failure

Volatile organic compounds have potential in heart failure diagnostics

24-PUL-4507382-CQD-Portopulmonary-Hypertension-Hero-967×544
January 26, 2024/Pulmonary/Research

Portopulmonary Hypertension: A Focused Review for the Internist

Insights for diagnosing, assessing and treating

opioids
December 6, 2023/Pulmonary/Research

Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects?

Two NIH grants are looking at developing new antidotes against fentanyl overdose

BackPage 1 of 6Next

Advertisement

Ad